enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Amikacin - Wikipedia

    en.wikipedia.org/wiki/Amikacin

    Amikacin is an antibiotic medication used for a number of ... granted the application for amikacin liposome inhalation suspension fast track, breakthrough ...

  3. Fast track (FDA) - Wikipedia

    en.wikipedia.org/wiki/Fast_track_(FDA)

    Fast track is a designation by the United States Food and Drug Administration (FDA) of an investigational drug for expedited review to facilitate development of drugs that treat a serious or life-threatening condition and fill an unmet medical need. Fast track designation must be requested by the drug company.

  4. Plazomicin - Wikipedia

    en.wikipedia.org/wiki/Plazomicin

    Plazomicin, sold under the brand name Zemdri, is an aminoglycoside antibiotic used to treat complicated urinary tract infections. [2] As of 2019 it is recommended only for those in whom alternatives are not an option. [2]

  5. AOL latest headlines, entertainment, sports, articles for business, health and world news.

  6. Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.

  7. List of antibiotics - Wikipedia

    en.wikipedia.org/wiki/List_of_antibiotics

    Amikacin: Amikin: Infections caused by Gram-negative bacteria, such as Escherichia coli and Klebsiella particularly Pseudomonas aeruginosa. Effective against aerobic bacteria (not obligate/facultative anaerobes) and tularemia. All aminoglycosides are ineffective when taken orally as the stomach will digest the drug before it goes into the ...

  8. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

  9. An experimental drug drove people to lose 23% of their body ...

    www.aol.com/news/novo-nordisk-next-generation...

    Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently approved medicine, Zepbound, but didn’t cleanly surpass it in late ...